Results 231 to 240 of about 174,148 (299)

Psychedelics as pharmacotherapeutics for substance use disorders: A scoping review on clinical trials and perspectives on underlying neurobiology

British Journal of Pharmacology, EarlyView.
Theorized mechanism of dopamine homeostasis restoration in the nucleus accumbens core induced by a psychedelic intervention. Abstract Psychedelics have garnered great attention in recent years as treatments for major depressive disorder (MDD) and treatment‐resistant depression because of their ability to alter consciousness and afflicted cognitive ...
Lucas Wittenkeller, Gary Gudelsky, T. John Winhusen, Davide Amato   +3 more
wiley   +1 more source

Interview with Dr. Errikos Maslias - 8^th European Congress on Neurorehabilitation in conjunction with the 20^th Congress of the Society for the Study of Neuroprotection and Neuroplasticity. [PDF]

J Med Life
Dobran SA, Gherman A.
europepmc   +1 more source

Is there a role for cannabidiol in obesity, metabolic syndrome and binge eating?

British Journal of Pharmacology, EarlyView.
Cannabidiol (CBD) is one of the most abundant phytocannabinoids isolated from the Cannabis sativa plant. CBD is a lipophilic, non‐intoxicating substance that differently from Δ9‐tetrahydrocannabinol (Δ9‐THC) does not present the typical profile of a drug of abuse.
Luca Botticelli, Emanuela Micioni Di Bonaventura, Giacomo Einaudi, Gustavo Provensi, Alessia Costa, Claudio D'Addario, Carlo Cifani, Maria Vittoria Micioni Di Bonaventura   +7 more
wiley   +1 more source

CRISPR-Based Therapy for Ischemic Stroke: A Narrative Review. [PDF]

Cell Mol Neurobiol
Alavian F, Ghasemi S.
europepmc   +1 more source

The potential for biased signalling in the P2Y receptor family of GPCRs

British Journal of Pharmacology, EarlyView.
The purinergic receptor family is primarily activated by nucleotides, and contains members of both the G protein coupled‐receptor (GPCR) superfamily (P1 and P2Y) and ligand‐gated ion channels (P2X). The P2Y receptors are widely expressed in the human body, and given the ubiquitous nature of nucleotides, purinergic signalling is involved with a plethora
Claudia M. Sisk, Simon Pitchford, Graham Ladds   +2 more
wiley   +1 more source

GABAergic ventrolateral preoptic projection to dorsomedial hypothalamus recapitulates post-ischemic neuroprotection by hypothermia. [PDF]

Cell Death Dis
Dilsiz P, Ozpinar A, Balaban B, Koç Hİ, Altunay S, Baltacı SB, Hapil FZ, Doeppner TR, Dzyubenko E, Beker MÇ, Hermann DM, Kılıç E.   +11 more
europepmc   +1 more source

Defining AV2‐1 as a novel pharmacological probe to target human and rodent TRPV2

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Transient receptor potential vanilloid 2 (TRPV2) is a non‐selective cation channel implicated in immune cell functions. However, progress in understanding TRPV2 has been limited by a lack of potent and selective pharmacological tools, particularly those targeting the human variant. We aimed to identify and characterise a
Andrea Leipe, Julia A. Rocereta, Ruth A. Pumroy, Andreas Leffler, Michael Schaefer, Vera Moiseenkova‐Bell, Kerstin Hill   +6 more
wiley   +1 more source

Editorial: Targeted drug delivery and mode of action of small molecules in neuroinflammation. [PDF]

Front Pharmacol
Patil VS, Khanal P, Harish DR.
europepmc   +1 more source

Timing of Delivery in Preeclampsia: Time to Reconsider?

BJOG: An International Journal of Obstetrics &Gynaecology, EarlyView.
Rebecca Horgan, Ahmed S. Z. Moustafa, Mackenzi Mchugh, Tetsuya Kawakita, Baha Sibai, George Saade   +5 more
wiley   +1 more source

Correction to "Nanocatalytic Neuroprotection and Neurological Recovery Post-Traumatic Brain Injury". [PDF]

Adv Sci (Weinh)
europepmc   +1 more source